Overcoming Drug Resistance: The EGFR Enigma, Part 2
This post explores the challenges we face with anti-EGFR monoclonal antibody therapies and new strategies researchers have developed to...
Category: Journals
This post explores the challenges we face with anti-EGFR monoclonal antibody therapies and new strategies researchers have developed to...
Currently, anti-EGFR therapies are approved by the U.S. Food and Drug Administration for the treatment of non-small cell lung...
In recognition of June as Cancer Immunotherapy Month, organized by our colleagues at the Cancer Research Institute (CRI), the...
AACR membership includes scientists and physicians from across the cancer research enterprise. Whether basic, translational, or clinical researchers, they...
Over the years, clinical research has become an integral part of the American Association for Cancer Research’s meetings and...
Guest Post by Scott M. Lippman, MD UC San Diego Moores Cancer Center
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...
A recent study in the AACR’s journal Cancer Epidemiology, Biomarkers & Prevention suggests that different types of cancer fear...
A major question that researchers are trying to answer is: What links obesity with cancer development and adverse survival?
Through think tanks, special conferences, and its Pediatric Cancer Working Group, the AACR is taking steps to establish childhood...